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Abstract
Background: Quality of cardiopulmonary resuscitation (CPR) is associated with survival, but recommended guidelines
are often not met, and less than half the children with an in-hospital arrest will survive to discharge. A single-center
before-and-after study demonstrated that outcomes may be improved with a novel training program in which all
pediatric intensive care unit staff are encouraged to participate in frequent CPR refresher training and regular, structured
resuscitation debriefings focused on patient-centric physiology.
Methods/design: This ongoing trial will assess whether a program of structured debriefings and point-of-care bedside
practice that emphasizes physiologic resuscitation targets improves the rate of survival to hospital discharge with
favorable neurologic outcome in children receiving CPR in the intensive care unit. This study is designed as a
hybrid stepped-wedge trial in which two of ten participating hospitals are randomly assigned to enroll in the
intervention group and two are assigned to enroll in the control group for the duration of the trial. The remaining six
hospitals enroll initially in the control group but will transition to enrolling in the intervention group at randomly assigned
staggered times during the enrollment period.
Discussion: To our knowledge, this is the first implementation of a hybrid stepped-wedge design. It was chosen over a
traditional stepped-wedge design because the resulting improvement in statistical power reduces the required enrollment
by 9 months (14%). However, this design comes with additional challenges, including logistics of implementing
an intervention prior to the start of enrollment. Nevertheless, if results from the single-center pilot are confirmed
in this trial, it will have a profound effect on CPR training and quality improvement initiatives.
Trial registration: ClinicalTrials.gov, NCT02837497. Registered on July 19, 2016.
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Background
Cardiac arrest occurs in 2–6% of patients admitted to a
pediatric intensive care unit (ICU) [1]. Less than half
survive to discharge [2–4]. Quality of cardiopulmonary
resuscitation (CPR) is associated with survival [5–9], but
recommended guidelines are often not met [5, 10].
Although standard courses are the mainstay of ongoing
life support training, the evidence that these courses
improve outcomes is modest [11–13]. Other approaches
to improve CPR quality include real-time CPR feedback
devices and structured postresuscitation debriefings.
Real-time CPR feedback devices report quantitative CPR
quality data (e.g., compression rate, depth, and release
velocity) and have been moderately effective at improving
psychomotor aspects of basic life support (e.g., chest
compressions) [14, 15], but data demonstrating improved
long-term outcomes are limited [16]. Comprehensive
reviews (debriefings) of resuscitation efforts for the physi-
cians involved in the resuscitation have improved CPR
quality but have not been found to increase the rate of
survival to hospital discharge [17]. Their lack of effect-
iveness may be due to traditional debriefing programs
targeting only those providers who actually participated
in the event under review [17]. However, a novel approach
that incorporated patient-centric physiology into the review
and included the entire care environment (i.e., both pro-
viders who were and those who were not at the resuscitation
under review) has been associated with a higher rate of
survival with favorable neurologic outcome [18, 19].
The generalizability of the benefits resulting from
patient-centric physiologic debriefings with all potential
providers of the care environment is unclear because
this intervention has been evaluated only in a small,
single-center before-and-after study [19]. The 42-month
pediatric ICU study included an 18-month control period,
a 6-month transition period, and an 18-month interven-
tion period. The study enrolled 52 subjects with an index
(first) CPR event in the control period and 42 subjects in
the intervention period. The overall rate of survival with
favorable neurologic outcome increased from 29% in the
control period to 50% in the intervention period. Adjust-
ing for potentially prognostic variables (age, sex, and first
documented rhythm), subjects in the intervention period
were more likely to survive to hospital discharge with
favorable neurologic outcome (adjusted OR 2.75, 95%
CI 1.01–7.5; p = 0.047) [19]. Despite limitations, the results
suggest that this intervention may offer a powerful new
approach for improving outcomes of in-hospital pediatric
CPR. However, a multicenter randomized controlled trial is
needed to assess the generalizability of these findings.
Methods/design
The present study protocol was written in accordance
with Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT). A SPIRIT checklist is
provided in Additional file 1.
Objective
The primary aim of this ongoing multicenter trial,
Improving Outcomes from Pediatric Cardiac Arrest –
the ICU-Resuscitation Project (ICU-RESUS), is to assess
whether structured debriefings for the ICU care environ-
ment combined with point-of-care bedside practice will
improve the rate of survival with favorable neurologic
outcome in children receiving CPR in the ICU.
Design
Three types of designs were considered for this cluster
randomized trial: a parallel design, a traditional stepped-
wedge (TSW) design [20], and a hybrid stepped-wedge
(HSW) design (Fig. 1). In a parallel design, each hospital
is randomly assigned to either an intervention or control
group for the duration of the trial. In a TSW design,
each hospital begins enrolling in the control group and
transitions to enrolling in the intervention group at a
randomly assigned time. The design ultimately selected
for this trial is an HSW design, which is a hybrid between
the parallel and stepped-wedge designs. As in a parallel
design, two randomly selected hospitals are permanently
assigned to enroll in the control group, and two others are
permanently assigned to enroll in the intervention group.
The remaining six hospitals, as in a stepped-wedge design,
initially enroll in the control group but are randomly
assigned a time to transition to enrolling in the inter-
vention group. However, it is important to note that the
influence of the intervention on hospital staff and
thereby on patient outcomes is not fully effective on
the day that the intervention is initiated. Therefore,
each of these six hospitals has a brief transition period
during which outcome data will not be included in the
analysis. To our knowledge, ICU-RESUS is the first
implementation of an HSW design, one with several
advantages in the context of the trial.
An HSW design, like a TSW design, offers a logistically
feasible way to roll out a seemingly desirable intervention
for participating hospitals at staggered intervals while also
allowing a robust comparison between treatment and
control periods. In particular, the design enables valid
comparisons in the midst of underlying temporal trends
in the outcome. In contrast, a simple before-and-after
design, as in the single-center pilot study, cannot adequately
account for temporal trends, and any observed “intervention
effect” cannot be disentangled from other influencing factors
that may have changed over time. In addition to the advan-
tages of a TSW design, an HSW design has been reported,
in many instances, to have increased power compared with
a TSW design or a parallel group design [21].
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Intervention
The intervention is a two-part ongoing training program
for ICU staff. The program includes structured debriefings
for the entire care environment [19] (i.e., any care provider
from several disciplines: physicians, nurses, respiratory
therapists, extracorporeal support specialists) and point-
of-care practice with a manikin [22].
A 1-h CPR debriefing is held approximately monthly
(at least nine times per year) by the unit, and all ICU
staff are encouraged to attend. Providers are “invited” to
the sessions through emails and departmental flyers.
Ideally, a recent resuscitation from within the unit is
selected, but a de-identified case from another unit or
hospital may be used if needed. The purpose of these
debriefings is to carefully review aspects of care that
went well and aspects that could be improved [18]. The
case introduction includes relevant patient history and
details of the patient characteristics and medical manage-
ment preceding CPR. The debriefing then includes event
details such as precode cardiac rhythm, interruptions in
compressions, defibrillation attempts with pre- and post-
shock rhythm, ventilation, compression rate and depth, and
release velocity (leaning). When available, case presenta-
tions emphasize patient-centric physiologic CPR targets
using arterial catheter pressure tracings and end-tidal CO2
waveforms. Cases may also include important aspects of
pediatric postarrest care such as recognition of seizures
[23–25], prevention of fevers [26], and avoidance of
hypotension [27]. These sessions are protected under quality
improvement guidelines at the individual institutions.
Point-of-care bedside practice allows ICU staff to practice
chest compression delivery on a manikin that is set up on a
cart so that it can easily be brought to the clinicians
throughout the unit. Manikins are equipped to monitor
and provide real-time feedback on the quality of delivery
(e.g., rate, depth, and release velocity). Both infant and child
manikins are available for staff to practice on a model
that is relevant to their patients for the shift. Point-of-
care practice is frequent (≥ 48 per unit each month),
but brief (< 2 minutes) in duration. This component of
training was in place during both the control and interven-
tion periods of the single-center pilot study of team
debriefings and has been described previously [22, 28–30].
Participants
ICU-RESUS is supported by the National Heart, Lung,
and Blood Institute (NHLBI) and conducted by the Eunice
Kennedy Shriver National Institute of Child Health and
Human Development-funded Collaborative Pediatric
Critical Care Research Network (CPCCRN). Hospitals
were eligible for participation if they had not implemented
either of the elements of the ICU-RESUS intervention and
were committed to not implementing the intervention
until scheduled by the trial randomization. The ten par-
ticipating hospitals are geographically diverse tertiary
care pediatric hospitals with patients from a mixture of
urban, suburban, and rural areas of the United States
[31]. These hospitals include 18 distinct units from which
subjects will be enrolled.
All eligible subjects at participating institutions are
enrolled under a waiver of consent. The central institu-
tional review board at the University of Utah granted a
waiver of consent based on the following factors:
1. ICU-RESUS poses no more than minimal risk,
because CPR training already exists in the ICUs and
resuscitation quality should be at least as good with
the ICU-RESUS intervention.
Fig. 1 Comparison of cluster-randomized trial designs. This figure il-
lustrates the concept of a hybrid stepped-wedge (HSW) design com-
pared with a parallel group or traditional stepped-wedge (TSW)
design. a Parallel design. b TSW design. c HSW design
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2. The study involves no therapeutic intervention at
the patient level, because the intervention is
targeted to the care environment and does not
deviate from accepted clinical practice.
3. Obtaining informed consent would threaten the
scientific validity of the study, which depends on
capturing all eligible events during the enrollment
period.
Subjects are considered for eligibility if they (1) are ≥
37 weeks gestational age and ≤ 18 years of age and (2)
receive CPR in the ICU. Subjects are excluded if they,
prior to the arrest, (1) had a preexisting terminal illness
and were not expected to survive the hospitalization (e.g.,
patients transferred to the ICU for end-of-life care); (2)
had a lack of commitment to aggressive ICU therapies; (3)
were brain dead; or (4) had an out-of-hospital cardiac arrest
associated with the current hospitalization. CPR events
lasting < 1 minute will be excluded from analysis if a site
investigator determines CPR to have been unnecessary.
We anticipate enrolling 1540 index CPR events from 18
clinical units at 10 participating hospitals during a 4.5-year
enrollment period. A schedule of enrollment, interven-
tions, and assessment is provided in Fig. 2.
Randomization
The role of randomization in an HSW trial is to determine
which clusters will permanently enroll in the control
group, which will enroll permanently in the intervention
group, and the order in which the others will transition
from control to intervention (Fig. 1c). Although the ana-
lysis will control for each individual unit, randomization
occurs at the hospital level as opposed to the unit level to
prevent the possibility of contamination. If units within a
hospital were allowed to transition at different times, the
intervention in one unit might inadvertently influence
outcomes in the other, nontransitioned unit. One way that
contamination could happen is through staff members
from a transitioned unit temporarily working a shift in
the nontransitioned unit. Therefore, when multiple units
from a hospital are participating in the trial, all units are
assigned the same transition date, reducing the possibility
of contamination.
All possible permutations of the hospitals were considered
for the order in which hospitals would transition from con-
trol to intervention. However, some permutations lead to a
transition schedule in which the smallest hospitals transition
early and the largest hospitals transition late, causing more
subjects to be enrolled in the control group than in the
intervention group. The imbalance for each permutation
was estimated on the basis of hospital-specific enrollment
expectations, and permutations with excessive imbalance
were excluded. The permutation selected for implementa-
tion was then chosen at random from permutations with
adequate balance with respect to expected enrollment be-
tween intervention and control groups.
Fig. 2 Schedule of enrollment, interventions, and assessments. This figure illustrates the schedule of trial events, including enrollment,
interventions, and assessments. Point-of-care practice occurs ≥ 48 times per month in each transitioned or transitioning intensive care unit (ICU).
Debriefing occurs at least nine times per year at each transitioned or transitioning ICU. CPR Cardiopulmonary resuscitation, PCPC Pediatric Cerebral
Performance Category scale, PRISM Pediatric Risk of Mortality score, a measure of illness severity based on assessments from 2 to 6 h prior to the
CPR event
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The timing of the intervention for each hospital was
established by the data coordinating center prior to
enrollment. At a participating hospital randomly selected
to transition from control to intervention, investigators
and trial staff are informed of their selection 3 months
prior to the assigned transition date. This time frame
was selected to provide hospitals with sufficient notice
to prepare for implementation while not divulging
assignment so far in advance as to potentially affect a
hospital’s resolve to stay the course. The scheduled hospital
is allowed a 4-week window to begin the transition by
holding an inaugural debriefing. The exact dates marking
the beginning and end of the transition period, a period
during which newly enrolled subjects are excluded from
analysis, is determined by the date on which the first and
fourth debriefings are held. Debriefings are held monthly,
making the transition period approximately 3 months.
Outcome assessment
As in the single center pilot study, the primary outcome is
survival to hospital discharge with favorable neurologic
outcome. Neurologic outcome is measured with the
Pediatric Cerebral Performance Category scale (PCPC
[32]) (Table 1) as per standard Utstein-style reporting
guidelines [33]. Survivors are considered to have a
favorable neurologic outcome if they have no worse
than moderate disability at hospital discharge (PCPC
score of 1, 2, or 3) or if their PCPC is no worse than at
baseline. Baseline PCPC is retrospectively assessed in
enrolled patients and is typically based on their status
prior to the event leading to the current hospitalization.
However, baseline PCPC is evaluated no more than 30
days prior to CPR for subjects who have been in the
hospital for more than 90 days. Subjects who are born
during the same hospitalization in which the CPR occurred
will have their baseline PCPC assessed based on their status
prior to the decompensation associated with the CPR
event. PCPC assessment is performed by unblinded
research coordinators on the basis of detailed objective
criteria [32].
Sample size calculation
In the single-center pilot, the intervention was associated
with an increase in survival with favorable neurologic out-
come from 29% to 50% (21 percentage points). We antici-
pate that we will see improvement to a rate similar to that
achieved in the single-center pilot, but preliminary data
from another study show that CPCCRN hospitals have a
higher average baseline rate of survival with favorable
neurologic outcome than the single-center pilot [34].
Therefore, our goal was to select a design and sample size
that would provide approximately 80% power (at a signifi-
cance level of α = 0.05) to detect a more conservative in-
crease from 40% to 51% in survival with favorable
neurologic outcome. An important factor for sample size
calculation in cluster-randomized trials is the intracluster
correlation (ICC), a measure of the similarity in outcomes
among patients in the same cluster compared with
outcomes among patients in different clusters [35]. The
ICC was assumed to be 3% on the basis of pilot data from
the multicenter Therapeutic Hypothermia after Pediatric
Cardiac Arrest In-Hospital Trial [36].
The power and sample size estimates used for planning
this trial were based on the method introduced by Hussey
and Hughes [37], though generalized to allow for transition
periods and implemented in PASS version 15 software
[38]. This method uses a Wald Z-test to evaluate a null
hypothesis of no effect against a two-sided alternative. We
considered several trial design configurations, including
parallel group, TSW, and HSW designs. We also investi-
gated the impact of transition duration. With an ICC of
3%, an HSW design was found to be optimal (Table 2)
Table 1 Pediatric Cerebral Performance Category scale
Score Category Description
1 Normal At age-appropriate level; school-age child
attend regular school
2 Mild disability Conscious, alert, able to interact at
age-appropriate level; regular school but
grades perhaps not age-appropriate,
possibility of mild neurologic deficit
3 Moderate
disability
Conscious, age-appropriate independent
activities of daily living; special education
classroom and/or learning deficit present
4 Severe disability Conscious, dependent on others for daily
support because of impaired brain function
5 Coma or vegetative
state
Any degree of coma, unaware, even if
awake in appearance, without interaction
with the environment; no evidence of
cortex function; possibility for some
reflexive response, spontaneous
eye-opening, sleep-wake cycles
6 Brain death/death Brain death, death
Table 2 Required duration of enrollment to achieve > 80% power
Duration of enrollment (years)a
Trial design
Parallel NAb
Traditional stepped-wedge
6-month transition 6
3-month transition 5.25
Hybrid stepped-wedge
6-month transition 4.75
3-month transition 4.5
aDuration of enrollment is the approximate number of years required to
achieve > 80% power to detect an increase from 40% to 51% in the rate of
survival with favorable neurologic outcome
bIn this context, a parallel design cannot achieve 80% power, regardless of the
duration of enrollment
Reeder et al. Trials  (2018) 19:213 Page 5 of 10
[21, 39]. Long transition periods in HSW and especially
in TSW designs increased the trial duration necessary
to achieve > 80% power (Table 2). Therefore, an HSW
design was selected with short (3-month) transitions.
To estimate power for the HSW design, we assume
that two hospitals, each with two units, are randomly
assigned to begin with the intervention, and similarly
that four units at two hospitals are assigned to remain as
control hospitals for the duration of the study. Enrollment
was assumed to be evenly distributed across the 18 units
and also across the 18 time periods. A 3-month transition
period was included for each of the ten transitioning units
in the design-pattern matrix (Table 3). Units are the
clusters used for sample size calculations and planned
analyses. However, as noted above, randomization occurs
at the hospital level to minimize the possibility of inter-
vention contamination between units within a hospital.
We found that analyzing 1256 index events (4 per unit
per period) would provide 77% power to detect an 11-
percentage-point increase in the rate of survival with
favorable neurologic outcome from a baseline rate of
40%. Power increases to 84% when analyzing 1570
index events (5 per unit per period). On the basis of
concavity of the power curve, analyzing 1391 subjects
provides > 80% power. On the basis of historical CPR
rates in participating units, we anticipate enrolling 1540
index events over the 4.5-year enrollment period. An
estimated 48 index events will occur during the transition
periods, allowing analysis of the remaining 1492 events
and providing > 80% power.
Data management
Data collected for this trial are entered into OpenClinica,
a web-based electronic data capture system, and stored
on a secure server at the data coordinating center. An
automated system for validating data against a set of
predefined rules will query clinical centers regarding data
that are invalid, illogical, or incomplete. Data elements crit-
ical to the primary aim of this trial are monitored remotely
by the data coordinating center to confirm the accuracy of
entered data compared with the source documents. Remote
monitoring is performed on initial subjects enrolled at each
clinical center and then on a subset of additional subjects
enrolled throughout the trial.
Statistical analysis
The primary analysis is to assess the effect of the interven-
tion on survival with favorable neurologic outcome. This
analysis is based on subjects enrolled during the control
period or the intervention period and excludes subjects
enrolled during the transition period. Secondary events
(after the first eligible CPR event) during the hospitalization
Table 3 Design-pattern matrix for sample size calculations in a 4.5-year hybrid stepped-wedge design with 3-month transitions
Unit Time period (18 × 3 months)
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 T13 T14 T15 T16 T17 T18
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 . 1 1
6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 . 1 1
7 0 0 0 0 0 0 0 0 0 0 0 0 . 1 1 1 1 1
8 0 0 0 0 0 0 0 0 0 0 0 0 . 1 1 1 1 1
9 0 0 0 0 0 0 0 0 0 . 1 1 1 1 1 1 1 1
10 0 0 0 0 0 0 0 0 0 . 1 1 1 1 1 1 1 1
11 0 0 0 0 0 0 . 1 1 1 1 1 1 1 1 1 1 1
12 0 0 0 0 0 0 . 1 1 1 1 1 1 1 1 1 1 1
13 0 0 0 . 1 1 1 1 1 1 1 1 1 1 1 1 1 1
14 0 0 0 . 1 1 1 1 1 1 1 1 1 1 1 1 1 1
15 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
16 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
17 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
18 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Each cell represents the intervention status of a unit in a given 3-month period. Zero indicates that the unit has not started the intervention; 1 indicates that the
unit has completed the transition; and a dot indicates that the unit is in midtransition
Reeder et al. Trials  (2018) 19:213 Page 6 of 10
are excluded. The effect of the intervention will be assessed
with the following test of hypothesis:
H0: The intervention does not affect the rate of survival
with favorable neurologic outcome.
H1: The intervention increases or decreases the rate of
survival with favorable neurologic outcome.
Survival with favorable neurologic outcome will be the
outcome for a multivariable logistic regression model.
The primary predictor in the model will be treatment
group (intervention vs. control). Fixed covariates in the
model will be age category (≤ 6 months, > 6 months),
Pediatric Risk of Mortality score (PRISM; a measure of
illness severity in the 2–6 h prior to CPR) [40], first
documented rhythm, illness category (medical cardiac,
surgical cardiac, medical noncardiac, surgical noncar-
diac), and a piecewise linear spline of time. Age, illness
category and severity, and first documented rhythm are
known predictors of mortality and are included to improve
the model fit and potentially increase power. In contrast,
survival with favorable neurologic outcome is not expected
to change over time. However, without adjusting for time,
an improvement over time in survival with favorable
neurologic outcome that is unrelated to the intervention
would be erroneously interpreted as evidence for the inter-
vention owing to the increased enrollment in the interven-
tion group toward the end of the trial. Including time as a
covariate is critical for TSW and HSW designs in order to
have valid inference in case of potential temporal trends.
Although time is often modeled as a categorical variable in
TSW trials, we chose to model time as a piecewise linear
spline because we expect it to provide better model fit with
fewer estimated parameters. For the spline, knots will
divide the enrollment period into epochs of equal duration.
The number of knots will be chosen to minimize the
Akaike information criterion. There are 18 distinct units at
the 10 participating hospitals. Unit will be included as a
random effect to account for variability in outcomes
between units and increase the generalizability of results.
The data needed for this analysis are readily available,
and automated data validation ensures that critical mea-
surements are entered. However, in a very small number
of subjects, the window for the PRISM score will be
entirely prior to hospitalization. In order to obtain a best
estimate of prearrest severity of illness, measurements
more than 30 minutes prior to the arrest may be used in
this case. In the very rare case that a subject experiences a
CPR event within the first 30 minutes of hospitalization,
all values will be assumed to be normal prior to the
decompensation associated with the CPR event.
This trial compares the effect of the ICU-RESUS inter-
vention to current practice, but participating units had
varied quality improvement programs prior to this trial.
Although participating units are committed to imple-
menting the ICU-RESUS intervention as scheduled by
randomization, they are free to continue, modify, or
supplement existing programs with other interventions.
The programs in place in each unit will be tracked
throughout the trial to allow a description of the control
group and an exploratory investigation of additional
elements of a successful program.
Data and safety monitoring
The NHLBI appointed an independent data and safety
monitoring board (DSMB) to monitor study progress,
adherence to the protocol, participant safety, and efficacy.
The DSMB has initially planned to meet after the first,
second, and third years of enrollment. Formal efficacy
monitoring is not planned until after the second year,
owing to the sigmoidal growth of the information fraction
for TSW and HSW designs and because very early trends
may not be representative. In particular, TSW and HSW
designs have many more subjects enrolled in the control
group than in the intervention group at interim time
points. However, efficacy monitoring remains important
to allow early stopping and dissemination of results in
case of a very large intervention effect, as was observed in
the single-center pilot study [19]. Efficacy monitoring will
be conducted with the Lan-DeMets approach for flexible
alpha spending [41], using conservative O’Brien-Fleming
boundaries for early stopping [42].
Discussion
More than half of the children experiencing an in-hospital
cardiac arrest will die prior to hospital discharge [2–4].
Achieving recommended targets for chest compression
rate, depth, and limiting interruptions in CPR have all
been associated with cardiac arrest outcome [6, 7, 43–47].
However, several studies have demonstrated that even
health care providers have difficulty meeting these metrics
during real-life resuscitations [10, 48–52]. CPR quality is
variable, and standard training courses have demonstrated
limited success [5, 10–13]. In short, conventional training
methods are failing.
However, there is preliminary evidence suggesting that
structured debriefings for the entire care environment
may improve outcomes. In particular, a single-center be-
fore-and-after pilot study showed an improvement from
29% to 50% in survival with favorable neurologic outcome
[19]. These impressive findings have been highlighted by
the Institute of Medicine as an exciting approach that
should be disseminated to improve outcomes for the >
200,000 adults and children with in-hospital cardiac arrest
in the United States each year [53]. Nevertheless, it is
important to validate the results of the small, single-center
before-and-after study in a larger multicenter trial.
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If the results from the single-center pilot study are
found to be generalizable, it will have a profound effect
on CPR training and quality improvement initiatives,
resulting in improved outcomes for children and their
families. Assuming roughly 6000 pediatric in-hospital
arrests annually [54] and an 11-percentage-point increase in
the rate of survival with favorable neurologic outcome, the
successful completion of this trial and national dissemin-
ation may save the lives of more than 600 children annually.
A TSW design is a relatively new, pragmatic trial design
that is now frequently used to assess the effect of an inter-
vention on a community. The HSW design is similar but
often provides more power [21, 39], especially when
transition periods are essential. To our knowledge, ICU-
RESUS is the first implementation of an HSW design. The
ICU-RESUS trial uses an HSW design with short transi-
tion periods to reduce the sample size, study duration, and
cost. The transition period in the single-center pilot was 6
months, with debriefings held every 6–8 weeks. However,
we found that these long transition periods had a detri-
mental effect on power for HSW designs and especially
for TSW designs. Using a shorter but more intense transi-
tion period (3 months instead of 6 months with debrief-
ings held every 4 weeks) and using an HSW design rather
than a TSW design allowed the duration of the trial to be
reduced from 6 years to 4.5 years, with accompanying
reduction in sample size and cost. The effect of transition
duration is so striking because the most influential obser-
vations are those immediately prior to and after crossover.
Therefore, when a period of transition is included, the
observations containing the most statistical information
are lost. The effect is somewhat subdued in an HSW
design because some hospitals do not cross over and
therefore do not experience a transition. Nevertheless,
transition periods for both TSW and HSW trials should
be as short as possible while still allowing the effect of the
intervention to be fully realized. This was achieved in
ICU-RESUS by increasing the intensity of the intervention
during the transition with more frequent debriefings,
which allowed the transition period to be reduced from 6
to 3 months.
Most of the challenges of implementing an HSW trial
are the same as for a trial with a TSW design. However,
an HSW design introduces a few unique challenges,
including the logistics of implementing an intervention
prior to the start of enrollment and institutional willingness
to participate. In a TSW trial, the intervention is first
applied after a period of enrollment. In an HSW design,
some hospitals must start the intervention prior to the
enrollment period. This can add to the logistical complexity
of study startup. When a transition period is required, such
as in the ICU-RESUS trial, the start of enrollment may be
delayed until the first hospitals are fully transitioned and
ready to enroll in the intervention group. If the timeline is
inflexible, enrollment may need to begin before the first
hospitals have completed the transition to the intervention,
reducing statistical power.
Another potential challenge that is unique to an HSW
trial is that hospitals may not be willing to participate in
a trial in which they might never have the opportunity
to apply the seemingly beneficial intervention. However,
if true equipoise exists, there should be no preconceived
expectation that receiving the intervention will ensure
better outcomes. This issue required substantial discussion,
but all investigators and sites agreed that the results of the
small, single-center before-and-after pilot do not support a
generalizable conclusion about the effect of the interven-
tion or justify broad application of this resource-intensive
intervention without further study. Therefore, no reserva-
tions were expressed by investigators or by the institutional
review board in regard to the study design. To assuage
potential concerns that the remaining control hospitals
may be deprived of this potentially lifesaving program,
the investigators determined a priori that support will
be provided for the implementation of the intervention,
after trial completion, at those remaining control hospitals
if it proves to be effective.
In conclusion, the ICU-RESUS trial uses a pragmatic
and innovative design to determine whether structured
debriefings coupled with point-of-care bedside practice
can provide the much-needed improvement in pediatric
resuscitation outcomes. This trial has the potential to
profoundly impact pediatric in-hospital resuscitation out-
comes as well as training and quality improvement
initiatives. Additionally, our ongoing experience in the
implementation of this trial may serve as an example to
others of the practical benefits and challenges of using
an HSW design.
Trial status
The 4.5-year enrollment period began on October 1, 2016,
and will conclude on April 1, 2021. This protocol, version 1,
was approved on September 7, 2016.
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Additional file 1: SPIRIT checklist. (DOC 101 kb)
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